Status:

RECRUITING

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Lead Sponsor:

Roswell Park Cancer Institute

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Acute Lymphoblastic Leukemia, Pediatric

Eligibility:

All Genders

3-9 years

Phase:

NA

Brief Summary

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

Detailed Description

This is a pilot randomized controlled trial of the CareMeds program to assess feasibility and obtain preliminary efficacy data among families of young children (ages 3-9) with ALL. The objective of th...

Eligibility Criteria

Inclusion

  • Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
  • Parent has primary medication responsibility.
  • Pediatric patient aged 3-9 years
  • Child on therapy that includes home-based oral anti-cancer medication taken at home, such as 6-MP.
  • Parent has verbal English or Spanish fluency.
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion

  • Parent of a child who is not diagnosed nor being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
  • Parent does not have primary medication responsibility.
  • Pediatric patient aged 3-9 years
  • Pediatric patient is not on therapy that includes oral anti-cancer medication (e.g., 6-MP).
  • Parent does not have verbal English or Spanish fluency.
  • Parent is unwilling or unable to follow protocol requirements

Key Trial Info

Start Date :

November 7 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2027

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06074666

Start Date

November 7 2024

End Date

October 1 2027

Last Update

January 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Roswell Park Comprehensive Cancer Center

Buffalo, New York, United States, 14263